BIO-101 (Boostimmune)

N/A

Report date: 2025/04/26 20:00:06

Base Information

Drug NameBIO-101 (Boostimmune)
Drug Alias NameBIO-101BIO101
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-Neoplasm proteins
TargetsNeoplasm proteins
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)SarcopeniaGait Disorders, Neurologic +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesPuerto Rico +[6] 
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBoostimmune Inc
China Registration ClassN/A

Develop Information

Active CompaniesBoostimmune Inc
Inactive CompaniesBiophytis
Active IndicationsNeoplasms
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)SarcopeniaGait Disorders, Neurologic +[4] 

Other Information

ATC CodeN/A
Related LinksN/A